Tivicay PD TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: dolutegravir
Pack: Tivicay PD 5 mg dispersible tablet, 60, bottle
Brand name
(ARTG)
: TIVICAY PD dolutegravir (as sodium) 5 mg dispersible tablet bottleDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
TIVICAY and TIVICAY PD are indicated for the treatment of human immunodeficiency virus (HIV) infection in combination with other antiretroviral agents in adults and children of at least 4 weeks in age or older and weighing 3 kg or more (see Section 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE, Dual regimens).
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, dispersible
- Oral
- White, round, biconvex tablets debossed with SV H7S on one side and 5 on the other side
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Protect from Moisture
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 60 tablets pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient dolutegravir
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
